Antimicrobial Agents Practice Questions

Q: A diabetic patient developed cellulitis due to S. aureus, which was found to be methicillin resistant on the antibiotic sensitivity testing. All of the following antibiotics will be appropriate except ?

Imipenem. ***Imipenem*** - **Imipenem** is a carbapenem antibiotic that is effective against many Gram-positive and Gram-negative bacteria, but it is **not active against MRSA (methicillin-resistant *Staphylococcus aureus*)**. - MRSA strains are resistant to all beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems like imipenem, due to the presence of the **mecA gene** which encodes for an altered penicillin-binding protein (PBP2a). *Vancomycin* - **Vancomycin** is a glycopeptide antibiotic that is a primary choice for treating **MRSA infections**, including cellulitis. - It inhibits cell wall synthesis by binding to the D-Ala-D-Ala precursor, preventing cross-linking, and is specifically active against **Gram-positive bacteria**. *Teicoplanin* - **Teicoplanin** is another glycopeptide antibiotic, similar to vancomycin, and is also considered a suitable agent for treating **MRSA infections**. - It works by inhibiting bacterial cell wall synthesis and has a **longer half-life** than vancomycin, allowing for less frequent dosing. *Linezolid* - **Linezolid** is an oxazolidinone antibiotic known for its activity against **Gram-positive bacteria**, including **MRSA** and vancomycin-resistant enterococci (VRE). - It inhibits protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex.

Q: Ivermectin is indicated in the treatment of:

Scabies. ***Scabies*** - **Ivermectin** is an effective oral antiparasitic agent used to treat **scabies**, particularly in cases of widespread infestation, crusted scabies, or when topical treatments fail. - It acts by paralyzing and killing the **Sarcoptes scabiei mites** responsible for the infestation. *Dermatophytosis* - **Dermatophytosis** (ringworm) is a **fungal infection** of the skin, hair, or nails. - It is typically treated with **antifungal medications** (e.g., azoles, terbinafine), not ivermectin. *Tuberculosis* - **Tuberculosis** is a bacterial infection caused by **Mycobacterium tuberculosis**, primarily affecting the lungs. - Treatment involves a multi-drug regimen of **antibiotics** (e.g., rifampin, isoniazid), for several months. *Syphilis* - **Syphilis** is a sexually transmitted bacterial infection caused by **Treponema pallidum**. - The primary treatment for syphilis is **penicillin**, usually administered via injection.

Q: Contact lens staining occurs in which ATT drug?

Rifampicin. ***Rifampicin*** - **Rifampicin** causes **red-orange discoloration** of bodily fluids, including tears. - This discoloration can **permanently stain soft contact lenses**, making this an important patient counseling point. *INH (Isoniazid)* - **INH** is primarily associated with **hepatotoxicity** and **peripheral neuropathy** due to pyridoxine deficiency. - It does not cause significant discoloration of bodily fluids or contact lens staining. *Pyrazinamide* - **Pyrazinamide** is known for causing **hyperuricemia** and **hepatotoxicity**. - It does not lead to discoloration of bodily fluids or contact lenses. *Thioacetazone* - **Thioacetazone** (not a first-line ATT drug) is associated with severe **cutaneous hypersensitivity reactions**, including Stevens-Johnson syndrome. - It does not cause the characteristic discoloration or contact lens staining seen with rifampicin.

Q: Minimum TB resistance is seen with which drug?

Ethambutol. ***Ethambutol*** - Among the first-line anti-TB drugs, **Ethambutol** has the **lowest rates of resistance development** - Resistance to Ethambutol is **less common** than to other first-line drugs like Isoniazid or Rifampicin - This makes it a valuable component of TB treatment regimens, particularly in maintaining effectiveness of combination therapy - Ethambutol resistance does occur but is relatively uncommon compared to other first-line agents *Isoniazid* - **Isoniazid resistance** is very common, occurring in approximately 10-15% of TB cases globally - Resistance arises from mutations in genes like *katG* and *inhA*, affecting drug activation and target binding - Despite resistance concerns, it remains a cornerstone drug due to its high efficacy when susceptibility is present *Rifampicin* - **Rifampicin resistance** is less common than Isoniazid but still significant - **Rifampicin-resistant TB (RR-TB)** is a marker for multidrug-resistant TB (MDR-TB) and indicates more severe disease - Development of Rifampicin resistance necessitates longer treatment regimens with second-line drugs *Streptomycin* - Historically one of the first antibiotics used for TB, but **resistance developed relatively quickly and is now widespread** - Due to the **high prevalence of resistance**, Streptomycin is no longer considered a first-line drug in most treatment programs - Has the highest resistance rates among the options listed

Q: Not True about Bedaquiline

Contraindicated in pregnancy. ***Contraindicated in pregnancy*** - While bedaquiline's safety in pregnancy is not fully established, it is generally **not absolutely contraindicated** if the potential benefits outweigh the risks, especially in cases of MDR-TB. - Current guidelines suggest that it can be used with caution, and a woman taking bedaquiline should use **effective contraception** throughout treatment. *Inhibits mycobacterial ATP synthase* - This statement is **true**. Bedaquiline specifically targets the **F0F1-ATP synthase enzyme** in *Mycobacterium tuberculosis*. - By inhibiting this enzyme, bedaquiline disrupts the **energy production** pathway of the bacteria, leading to bacterial death. *Given in > 10 years aged patients* - This statement is **true**. Bedaquiline is approved for use in patients with **multidrug-resistant tuberculosis (MDR-TB)** who are **12 years of age and older**. - Its use in younger children is still under investigation, though some compassionate use cases exist. *Given for MDR-TB patients* - This statement is **true**. Bedaquiline is a key drug in the treatment of **multidrug-resistant tuberculosis (MDR-TB)** and **extensively drug-resistant tuberculosis (XDR-TB)**. - It is often used as part of a **combination regimen** to overcome drug resistance to first-line agents.

Q: Persistent suppression of microbial growth below MIC is known as:

Post antibiotic effect. ***Post antibiotic effect*** - This phenomenon refers to the continued **suppression of bacterial growth** even after the antibiotic concentration has fallen below the **minimum inhibitory concentration (MIC)**. - It allows for less frequent dosing intervals without compromising efficacy. - Clinically important for **aminoglycosides and fluoroquinolones**, which exhibit significant PAE. *Paradoxical effect* - The **paradoxical effect** (or Eagle effect) refers to the phenomenon where certain antibiotics, particularly penicillin, become *less effective* at very high concentrations. - This effect is not about persistent suppression below MIC, but rather a **decreased bactericidal activity** at concentrations far exceeding MIC. *Post exposure prophylaxis* - **Post exposure prophylaxis (PEP)** refers to preventive treatment given after exposure to an infectious agent (e.g., HIV PEP, rabies PEP). - This is a clinical intervention strategy, not a pharmacodynamic phenomenon describing antibiotic behavior below MIC. *Adverse effect* - An **adverse effect** refers to an unintended and undesirable reaction to a drug, which is not relevant to the described microbial growth suppression. - This term describes harmful side effects experienced by the patient, not a microbiological phenomenon.

Q: Drugs of choice for MRSA in skin and soft tissue infections are:

Vancomycin, Linezolid. ***Vancomycin, Linezolid*** - **Vancomycin** is a cornerstone for treating **MRSA** infections, particularly severe ones, due to its efficacy against resistant staphylococci. - **Linezolid** is an alternative for **MRSA** infections, especially in cases of vancomycin resistance or intolerance, and offers good oral bioavailability. *Clindamycin, Vancomycin* - While **vancomycin** is correct, **clindamycin** has varying efficacy against **MRSA** and high rates of inducible resistance, making it less reliable as a primary drug of choice. - Clindamycin's use for MRSA often requires initial susceptibility testing, including a **D-test**, to rule out inducible clindamycin resistance. *Vancomycin, Teicoplanin* - **Vancomycin** is a primary **MRSA** drug, but **teicoplanin** is largely used in Europe and is structurally similar to vancomycin, often reserved for cases where vancomycin is not tolerated or preferred. - While effective, **teicoplanin** is not as universally recognized as a first-line option alongside vancomycin in all regions. *Dicloxacillin, Vancomycin* - **Vancomycin** is appropriate, but **dicloxacillin** is an **anti-staphylococcal penicillin** and is not effective against **MRSA** (Methicillin-Resistant Staphylococcus aureus) because MRSA, by definition, is resistant to all beta-lactam antibiotics. - Dicloxacillin is mainly used for **MSSA** (Methicillin-Sensitive Staphylococcus aureus) infections.

Q: Not true about iodophores?

Inorganic compounds. ***Inorganic compounds*** ✓ **Correct Answer** - This statement is **NOT TRUE** - Iodophores are **organic complexes**, not inorganic compounds. - They are formed by combining iodine with a **solubilizing agent** or carrier molecule, typically a surfactant or polymer (e.g., povidone-iodine). - This organic formulation allows for **controlled release** of iodine and reduces irritation compared to free iodine solutions. *Surfactants* - Many iodophores are formulated with **surfactants** to enhance their solubility and wettability. - These surfactants help to release the **active iodine** gradually, providing sustained antimicrobial action. *Release iodine* - Iodophores function by **slowly releasing free iodine**, which is the active antimicrobial agent. - This gradual release mechanism provides a **prolonged antiseptic effect** while minimizing irritation. *Disinfectant* - Iodophores are widely used as **disinfectants** and antiseptics in healthcare settings and for skin preparation. - Their broad-spectrum antimicrobial activity makes them effective against **bacteria, viruses, fungi, and spores**.

Q: Treatment of Neurocysticercosis includes all of the following except -

Niclosamide. ***Niclosamide***- **Niclosamide** is an oral anthelmintic primarily used to treat **intestinal tapeworm infections** by inhibiting **oxidative phosphorylation** in the parasites.- It has **poor systemic absorption** and therefore is **not effective** against **neurocysticercosis**, which involves cysts in the brain parenchyma requiring drugs with good CNS penetration.*Praziquantel*- **Praziquantel** is an orally administered anthelmintic that increases the **calcium permeability** of the parasite's cell membrane, leading to paralysis and death.- It is used in the treatment of **neurocysticercosis**, particularly for **viable parenchymal cysts** and as an alternative to albendazole [2].*Albendazole*- **Albendazole** is a broad-spectrum anthelmintic that works by inhibiting **tubulin polymerization**, causing disruption of **parasite metabolism** and glucose uptake.- It is considered the **first-line treatment** for **parenchymal neurocysticercosis** due to its excellent penetration into the central nervous system and proven efficacy.*Corticosteroids*- **Corticosteroids** (such as **dexamethasone** or **prednisolone**) are used as **adjunct therapy** in neurocysticercosis management.- They help reduce **inflammation and edema** associated with parasite death, preventing complications like seizures and increased intracranial pressure during anthelmintic treatment [1].

Q: Penicillin should be given to a patient with group A beta haemolytic streptococci infection of the tonsils for a period of:

10-14 days. ***10-14 days*** - A **10-day course** of oral penicillin is the standard recommendation for treating **Group A beta-hemolytic streptococcal (GABHS) pharyngitis** to ensure complete eradication of the organism. - This duration helps prevent complications like **acute rheumatic fever** and **acute post-streptococcal glomerulonephritis**. - Some guidelines extend treatment up to 14 days to ensure compliance and complete bacterial eradication. *21 days* - A 21-day antibiotic course is generally **too long** for uncomplicated GABHS pharyngitis and can increase the risk of antibiotic resistance or side effects. - This duration might be considered for more severe or recurrent infections, but not as an initial standard treatment. *3-5 days* - A 3-5 day course of antibiotics is **insufficient** for eradicating GABHS and significantly increases the risk of developing future complications like **rheumatic fever**. - While some antibiotics for other conditions have shorter courses, penicillin for strep throat requires a longer duration to be effective. *1 month* - A 1-month course of penicillin is **excessively long** for uncomplicated GABHS pharyngitis and is not indicated for this condition. - Such prolonged antibiotic therapy is typically reserved for ongoing prophylaxis in patients with a history of **rheumatic fever** or specific deep-seated infections.

Question 1

A diabetic patient developed cellulitis due to S. aureus, which was found to be methicillin resistant on the antibiotic sensitivity testing. All of the following antibiotics will be appropriate except ?

Accepted Answer

Imipenem

Answer

Vancomycin

Answer

Teicoplanin

Answer

Linezolid

Question 2

Ivermectin is indicated in the treatment of:

Accepted Answer

Scabies

Answer

Dermatophytosis

Answer

Tuberculosis

Answer

Syphilis

Question 3

Contact lens staining occurs in which ATT drug?

Accepted Answer

Rifampicin

Answer

INH

Answer

Thioacetazone

Answer

Pyrazinamide

Question 4

Minimum TB resistance is seen with which drug?

Accepted Answer

Ethambutol

Answer

Rifampicin

Answer

Streptomycin

Answer

Isoniazid

Question 5

Not True about Bedaquiline

Accepted Answer

Contraindicated in pregnancy

Answer

Inhibits mycobacterial ATP synthase

Answer

Given in > 10 years aged patients

Answer

Given for MDR-TB patients

Question 6

Persistent suppression of microbial growth below MIC is known as:

Accepted Answer

Post antibiotic effect

Answer

Paradoxical effect

Answer

Adverse effect

Answer

Post exposure prophylaxis

Question 7

Drugs of choice for MRSA in skin and soft tissue infections are:

Accepted Answer

Vancomycin, Linezolid

Answer

Clindamycin, Vancomycin

Answer

Vancomycin, Teicoplanin

Answer

Dicloxacillin, Vancomycin

Question 8

Not true about iodophores?

Accepted Answer

Inorganic compounds

Answer

Surfactants

Answer

Release iodine

Answer

Disinfectant

Question 9

Treatment of Neurocysticercosis includes all of the following except -

Accepted Answer

Niclosamide

Answer

Praziquantel

Answer

Albendazole

Answer

Corticosteroids

Question 10

Penicillin should be given to a patient with group A beta haemolytic streptococci infection of the tonsils for a period of:

Accepted Answer

10-14 days

Answer

21 days

Answer

3-5 days

Answer

1 month

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?